Systematic review of anticoagulant treatment of catheter-related thrombosis.

[1]  A. Delluc,et al.  Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients. , 2015, Thrombosis research.

[2]  H. Kantarjian,et al.  A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center , 2014, Cancer medicine.

[3]  A. Lamblin,et al.  Long-Term Efficacy and Safety of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE) in Tropique, a Prospective Non-Interventional Observational Study , 2014 .

[4]  P. Prandoni,et al.  The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. , 2014, Circulation.

[5]  J. Zwicker,et al.  Catheter‐associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH , 2014, Journal of thrombosis and haemostasis : JTH.

[6]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[7]  M. Prins,et al.  International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer , 2013, Journal of thrombosis and haemostasis : JTH.

[8]  P. Kamphuisen,et al.  Epidemiology and prevention of catheter‐related thrombosis in patients with cancer , 2012, Journal of thrombosis and haemostasis : JTH.

[9]  Paolo Prandoni,et al.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[10]  L. Sandvik,et al.  Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial , 2012, The Lancet.

[11]  Beppie van den Bogaerde,et al.  Clinical practice , 2011, European Journal of Pediatrics.

[12]  N. Kucher.  Clinical practice. Deep-vein thrombosis of the upper extremities. , 2011, The New England journal of medicine.

[13]  C. Flowers,et al.  Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters , 2010, Leukemia & lymphoma.

[14]  D Bergqvist,et al.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients , 2010, Journal of thrombosis and haemostasis : JTH.

[15]  F. Rosendaal,et al.  Recurrent Thrombosis and Survival After a First Venous Thrombosis of the Upper Extremity , 2008, Circulation.

[16]  C. Scarduelli,et al.  Deep venous thrombosis of the neck and pulmonary embolism in patients with a central venous catheter admitted to cardiac rehabilitation after cardiac surgery: a prospective study of 815 patients , 2008, Internal and emergency medicine.

[17]  M. Guil,et al.  Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry. , 2008, Chest.

[18]  S. Kahn,et al.  A pilot study of central venous catheter survival in cancer patients using low‐molecular‐weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study) , 2007, Journal of thrombosis and haemostasis : JTH.

[19]  P. Prandoni,et al.  Upper extremity DVT in oncological patients: analysis of risk factors. Data from the RIETE registry. , 2006, Experimental oncology.

[20]  S. Kahn,et al.  The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review. , 2006, Thrombosis research.

[21]  A. Hingorani,et al.  Morbidity and Mortality Associated with Internal Jugular Vein Thromboses , 2005, Vascular and endovascular surgery.

[22]  S. Schulman,et al.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.

[23]  T. Jacob,et al.  Risk factors for mortality in patients with upper extremity and internal jugular deep venous thrombosis. , 2005, Journal of vascular surgery.

[24]  S. Kahn,et al.  Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults , 2004, Thrombosis and Haemostasis.

[25]  U. Yetkin,et al.  Upper Extremity Deep Vein Thrombosis: Clinical and Treatment Characteristics , 2004, The Journal of international medical research.

[26]  M. Armon,et al.  Thrombolysis for acute deep vein thrombosis , 1996, The Cochrane database of systematic reviews.

[27]  P. Stein,et al.  Upper extremity deep venous thrombosis. , 2003, Chest.

[28]  A. Munkarah,et al.  Upper extremity deep vein thrombosis associated with indwelling peripheral venous catheters in gynecology oncology patients. , 2003, Gynecologic oncology.

[29]  Michael K Gould,et al.  Preventing complications of central venous catheterization. , 2003, The New England journal of medicine.

[30]  Paolo Prandoni,et al.  Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. , 2002, Blood.

[31]  P. Monagle,et al.  Post-thrombotic syndrome , 2002, Archives of disease in childhood.

[32]  P. Massoure,et al.  [Upper extremity deep venous thrombosis. 40 hospitalized patients]. , 2000, Journal des maladies vasculaires.

[33]  K. Savage,et al.  Outpatient Use of Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis of the Upper Extremity , 1999, Thrombosis and Haemostasis.

[34]  R. Bona,et al.  Regional Thrombolysis with Urokinase for Central Venous Catheter-related Thrombosis in Patients Undergoing High-dose Chemotherapy with Autologous Blood Stem Cell Rescue , 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[35]  A. Hingorani,et al.  Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. , 1997, Journal of vascular surgery.

[36]  A. Fernandez-cruz,et al.  [Axillary-subclavian thrombosis: review of its etiology and features in recent years]. , 1997, Anales de Medicina Interna.

[37]  J. Doppman,et al.  Pulse-spray treatment of subclavian and jugular venous thrombi with recombinant tissue plasminogen activator. , 1996, Journal of vascular and interventional radiology : JVIR.

[38]  B. Leduc,et al.  Fibrinolyse des thromboses veineuses profondes sur dispositifs de perfusion implantables. A propos d'une série consécutive de 57 thromboses et de 32 fibrinolyses. , 1996 .

[39]  S. Lefort,et al.  [Fibrinolysis of deep venous thrombosis on implantable perfusion devices. Apropos of a consecutive series of 57 cases of thrombosis and 32 cases of fibrinolysis]. , 1996, Bulletin du cancer.

[40]  M. Monreal,et al.  Pulmonary Embolism in Patients with Upper Extremity DVT Associated to Venous Central Lines - A Prospective Study , 1994, Thrombosis and Haemostasis.

[41]  W. L. Skinner,et al.  Groshong catheter-associated subclavian venous thrombosis. , 1993, The American journal of medicine.

[42]  A. AbuRahma,et al.  Axillary subclavian vein thrombosis. Changing patterns of etiology, diagnostic, and therapeutic modalities. , 1991, The American surgeon.

[43]  L. Greenfield,et al.  Axillary-Subclavian Vein Thrombosis: , 1991 .

[44]  L. Hollier,et al.  Axillary-subclavian venous occlusion: the morbidity of a nonlethal disease. , 1986, Journal of vascular surgery.